Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. N-(3-(5-(2-cyclopropylpyrimidin-5-yl)-1h-pyrrolo(2,3-b)pyridine-3-carbonyl)-2,4-difluorophenyl)-3-fluoropyrrolidine-1-sulfonamide
2. Plx8394
1. Plx8394
2. 1393466-87-9
3. Plx-8394
4. J2l7z273sg
5. Plx 8394
6. (3r)-n-[3-[5-(2-cyclopropylpyrimidin-5-yl)-1h-pyrrolo[2,3-b]pyridine-3-carbonyl]-2,4-difluorophenyl]-3-fluoropyrrolidine-1-sulfonamide
7. 1-pyrrolidinesulfonamide, N-(3-((5-(2-cyclopropyl-5-pyrimidinyl)-1h-pyrrolo(2,3-b)pyridin-3-yl)carbonyl)-2,4-difluorophenyl)-3-fluoro-, (3r)-
8. Unii-j2l7z273sg
9. Gtpl9131
10. Chembl4303729
11. Schembl15666953
12. Plx 8394 [who-dd]
13. Bdbm317826
14. Bcp19619
15. Ex-a1461
16. Plx 8394;plx8394
17. Nsc797932
18. Nsc801007
19. S7965
20. Zinc144705377
21. Cs-5123
22. Nsc-797932
23. Nsc-801007
24. Us9624213, Compound P-0338
25. Ncgc00483921-01
26. Ac-36850
27. Bp168493
28. Bs-15485
29. Hy-18972
30. A16840
31. D83660
32. A900333
33. Q27088419
Molecular Weight | 542.5 g/mol |
---|---|
Molecular Formula | C25H21F3N6O3S |
XLogP3 | 2.8 |
Hydrogen Bond Donor Count | 2 |
Hydrogen Bond Acceptor Count | 11 |
Rotatable Bond Count | 7 |
Exact Mass | 542.13479421 g/mol |
Monoisotopic Mass | 542.13479421 g/mol |
Topological Polar Surface Area | 129 Ų |
Heavy Atom Count | 38 |
Formal Charge | 0 |
Complexity | 976 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 1 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE
25
PharmaCompass offers a list of Plixorafenib API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Plixorafenib manufacturer or Plixorafenib supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Plixorafenib manufacturer or Plixorafenib supplier.
PharmaCompass also assists you with knowing the Plixorafenib API Price utilized in the formulation of products. Plixorafenib API Price is not always fixed or binding as the Plixorafenib Price is obtained through a variety of data sources. The Plixorafenib Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A PLX8394 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of PLX8394, including repackagers and relabelers. The FDA regulates PLX8394 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. PLX8394 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A PLX8394 supplier is an individual or a company that provides PLX8394 active pharmaceutical ingredient (API) or PLX8394 finished formulations upon request. The PLX8394 suppliers may include PLX8394 API manufacturers, exporters, distributors and traders.
PLX8394 Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of PLX8394 GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right PLX8394 GMP manufacturer or PLX8394 GMP API supplier for your needs.
A PLX8394 CoA (Certificate of Analysis) is a formal document that attests to PLX8394's compliance with PLX8394 specifications and serves as a tool for batch-level quality control.
PLX8394 CoA mostly includes findings from lab analyses of a specific batch. For each PLX8394 CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
PLX8394 may be tested according to a variety of international standards, such as European Pharmacopoeia (PLX8394 EP), PLX8394 JP (Japanese Pharmacopeia) and the US Pharmacopoeia (PLX8394 USP).